Analyst Ratings (USA)
Analysts raised more price targets than they cut on Nov 3rd, but sentiment varied across sectors. Healthcare drew some of the strongest upward revisions, particularly in select biotech and medical technology names. Technology was split, with target increases for some enterprise software stocks and repeated cuts across semiconductors, chip equipment and optical components. Financials showed pockets of strength in insurance brokerage and regional banks, while consumer coverage was mixed, with target increases in beauty, household products and lodging alongside cuts in auto retail. Energy and housing showed more caution, with downgrades in oil and gas and weaker calls on homebuilders and real estate platforms.
Updates (426)
Adeia (ADEA) — Rosenblatt Securities lowered its price target to $35.00 from $40.00 and listed a Buy rating.
Adidas AG (ADDYY) — UBS downgraded the stock to Sell from Neutral.
Advanced Energy Industries (AEIS) — Cantor Fitzgerald reiterated its Overweight rating.
Advanced Energy Industries (AEIS) — Citigroup lowered its price target to $450.00 from $460.00 and listed a Buy rating.
Advanced Energy Industries (AEIS) — Morgan Stanley lowered its price target to $368.00 from $375.00 and listed a Overweight rating.
Advanced Energy Industries (AEIS) — Robert W. Baird lowered its price target to $330.00 from $410.00 and listed a Outperform rating.
Advanced Energy Industries (AEIS) — TD Cowen lowered its price target to $275.00 from $370.00 and listed a Hold rating.
Advanced Energy Industries (AEIS) — Wells Fargo & Company lowered its price target to $310.00 from $360.00 and listed a Overweight rating.
Afya (AFYA) — Citigroup upgraded the stock to Buy from Neutral with a $12 price target.
Afya (AFYA) — JPMorgan Chase & Co. lowered its price target to $17.50 from $19.00 and listed a Overweight rating.
Airbnb (ABNB) — Raymond James Financial reiterated its Outperform rating.
Airbnb (ABNB) — UBS Group raised its price target to $181.00 from $172.00 and listed a Neutral rating.
AIRO Group Holdings (AIRO) — Roth Capital initiated coverage with a Buy rating and a $16 price target.
Alexandria Real Estate Equities (ARE) — Royal Bank Of Canada lowered its price target to $47.00 from $51.00 and listed a Sector Perform rating.
Allegion (ALLE) — Morgan Stanley raised its price target to $181.00 from $170.00 and listed a Equal Weight rating.
Alpine Income Property Trust (PINE) — Truist Financial lowered its price target to $17.00 from $19.00 and listed a Hold rating.
American Electric Power (AEP) — Jefferies Financial Group set its price target to $153.00.
Aon (AON) — BMO Capital Markets upgraded the stock to Outperform from Market Perform with a $380 price target.
Appian (APPN) — TD Cowen raised its price target to $50.00 from $30.00 and listed a Hold rating.
Apple (AAPL) — Argus raised its price target to $400.00 from $375.00 and listed a Buy rating.
Apple (AAPL) — Barclays raised its price target to $261.00 from $245.00 and listed a Underweight rating.
Apple (AAPL) — DA Davidson raised its price target to $295.00 from $270.00 and listed a Neutral rating.
Apple (AAPL) — Guggenheim set its price target to $400.00.
Apple (AAPL) — JPMorgan Chase & Co. lowered its price target to $355.00 from $360.00 and listed a Overweight rating.
Apple (AAPL) — KeyCorp reiterated its Underweight rating with a $250.00 price target.
Apple (AAPL) — Melius Research set its price target to $370.00.
Apple (AAPL) — Morgan Stanley set its price target to $350.00 from $355.00 and listed a Overweight rating.
Apple (AAPL) — Raymond James Financial reiterated its Market Perform rating.
Apple (AAPL) — Robert W. Baird set its price target to $340.00 from $330.00 and listed a Outperform rating.
Apple (AAPL) — Rosenblatt Securities reiterated its Neutral rating with a $303.00 price target.
Apple (AAPL) — TD Cowen lowered its price target to $390.00 from $400.00 and listed a Buy rating.
Apple (AAPL) — UBS Group set its price target to $370.00.
Apple (AAPL) — UBS Group reiterated its Neutral rating with a $340.00 price target.
Applied Materials (AMAT) — Morgan Stanley lowered its price target to $538.00 from $563.00 and listed a Equal Weight rating.
Arthur J. Gallagher (AJG) — BMO Capital Markets downgraded the stock to Market Perform from Outperform with a $295 price target.
Arvinas (ARVN) — HC Wainwright lowered its price target to $13.00 from $18.00 and listed a Buy rating.
Assembly Biosciences (ASMB) — UBS Group lowered its price target to $48.00 from $52.00 and listed a Buy rating.
Associated Banc (ASB) — Barclays raised its price target to $37.00 from $35.00 and listed a Overweight rating.
Atlassian (TEAM) — TD Cowen raised its price target to $180.00 from $145.00 and listed a Hold rating.
AutoNation (AN) — Barclays lowered its price target to $220.00 from $230.00 and listed a Overweight rating.
AutoNation (AN) — Citigroup lowered its price target to $240.00 from $255.00 and listed a Buy rating.
AvePoint (AVPT) — TD Cowen raised its price target to $18.00 from $15.00 and listed a Buy rating.
Axsome Therapeutics (AXSM) — Guggenheim lowered its price target to $250.00 from $275.00 and listed a Buy rating.
Axsome Therapeutics (AXSM) — Morgan Stanley raised its price target to $249.00 from $247.00 and listed a Equal Weight rating.
Axsome Therapeutics (AXSM) — Robert W. Baird lowered its price target to $220.00 from $246.00 and listed a Outperform rating.
Axsome Therapeutics (AXSM) — Royal Bank Of Canada lowered its price target to $273.00 from $295.00 and listed a Outperform rating.
Axsome Therapeutics (AXSM) — UBS Group lowered its price target to $239.00 from $256.00 and listed a Buy rating.
Axsome Therapeutics (AXSM) — Wells Fargo & Company reiterated its Outperform rating.
Backblaze (BLZE) — Citigroup reiterated its Market Outperform rating.
Backblaze (BLZE) — Needham & Company LLC lowered its price target to $15.00 from $23.00 and listed a Buy rating.
Bancorp (TBBK) — Raymond James Financial reiterated its Outperform rating with a $57.00 price target.
Biohaven (BHVN) — Morgan Stanley raised its price target to $21.00 from $19.00 and listed a Overweight rating.
BioMarin Pharmaceutical (BMRN) — Cantor Fitzgerald reiterated its Overweight rating.
BioMarin Pharmaceutical (BMRN) — HC Wainwright reiterated its Neutral rating with a $60.00 price target.
BioMarin Pharmaceutical (BMRN) — Morgan Stanley lowered its price target to $119.00 from $122.00 and listed a Overweight rating.
BioMarin Pharmaceutical (BMRN) — Oppenheimer lowered its price target to $94.00 from $97.00 and listed a Outperform rating.
BioMarin Pharmaceutical (BMRN) — Royal Bank Of Canada lowered its price target to $60.00 from $62.00 and listed a Sector Perform rating.
BioMarin Pharmaceutical (BMRN) — Stifel Nicolaus lowered its price target to $66.00 from $70.00 and listed a Hold rating.
Bioventus (BVS) — Canaccord Genuity Group lowered its price target to $18.00 from $19.00 and listed a Buy rating.
Blackstone Mortgage Trust (BXMT) — UBS Group lowered its price target to $14.00 from $21.00 and listed a Buy rating.
Block (XYZ) — BMO Capital Markets reiterated its Hold rating.
Block (XYZ) — Citigroup upgraded the stock to Outperform from Buy.
Bloom Energy (BE) — Barclays upgraded the stock to Overweight from Equal Weight with a $289 price target.
Bloom Energy (BE) — BMO Capital Markets downgraded the stock to Market Perform from Outperform.
Boise Cascade (BCC) — DA Davidson set its price target to $99.00.
Booking (BKNG) — UBS Group lowered its price target to $265.00 from $274.00 and listed a Buy rating.
Bright Minds Biosciences (DRUG) — Robert W. Baird lowered its price target to $107.00 from $126.00 and listed a Outperform rating.
BrightSpring Health Services (BTSG) — Guggenheim raised its price target to $84.00 from $81.00 and listed a Buy rating.
Cactus (WHD) — Citigroup raised its price target to $74.00 from $73.00 and listed a Neutral rating.
Cactus (WHD) — Piper Sandler raised its price target to $78.00 from $75.00 and listed a Overweight rating.
Canadian National Railway (CNI) — Susquehanna raised its price target to $140.00 from $130.00 and listed a Neutral rating.
Canadian Pacific Kansas City (CP) — Susquehanna raised its price target to $105.00 from $98.00 and listed a Positive rating.
Century Aluminum (CENX) — B. Riley Financial lowered its price target to $64.00 from $72.00 and listed a Buy rating.
Charter Communications (CHTR) — Citigroup lowered its price target to $140.00 from $180.00 and listed a Buy rating.
Check Point Software Technologies (CHKP) — Barclays raised its price target to $155.00 from $140.00 and listed a Equal Weight rating.
Check Point Software Technologies (CHKP) — BTIG Research reiterated its Neutral rating.
Check Point Software Technologies (CHKP) — Cantor Fitzgerald reiterated its Neutral rating with a $150.00 price target.
Check Point Software Technologies (CHKP) — Citigroup raised its price target to $145.00 from $130.00 and listed a Neutral rating.
Check Point Software Technologies (CHKP) — JPMorgan Chase & Co. lowered its price target to $155.00 from $167.00 and listed a Neutral rating.
Check Point Software Technologies (CHKP) — Morgan Stanley lowered its price target to $131.00 from $133.00 and listed a Equal Weight rating.
Check Point Software Technologies (CHKP) — Robert W. Baird lowered its price target to $170.00 from $175.00 and listed a Outperform rating.
Check Point Software Technologies (CHKP) — Royal Bank Of Canada raised its price target to $140.00 from $135.00 and listed a Sector Perform rating.
Check Point Software Technologies (CHKP) — Scotiabank lowered its price target to $175.00 from $185.00 and listed a Sector Outperform rating.
Check Point Software Technologies (CHKP) — Susquehanna raised its price target to $165.00 from $150.00 and listed a Positive rating.
Check Point Software Technologies (CHKP) — UBS Group raised its price target to $150.00 from $145.00 and listed a Neutral rating.
Check Point Software Technologies (CHKP) — Wells Fargo & Company raised its price target to $135.00 from $130.00 and listed a Equal Weight rating.
Cheniere Energy (LNG) — Scotiabank raised its price target to $327.00 from $311.00 and listed a Sector Outperform rating.
Cheniere Energy (LNG) — TD Cowen raised its price target to $352.00 from $325.00 and listed a Buy rating.
Chevron (CVX) — DZ Bank downgraded the stock to Hold from Buy with a $240 price target.
Choice Hotels International (CHH) — Barclays raised its price target to $107.00 from $103.00 and listed a Underweight rating.
Church & Dwight (CHD) — Barclays raised its price target to $89.00 from $83.00 and listed a Underweight rating.
Church & Dwight (CHD) — TD Cowen reiterated its Hold rating with a $115.00 price target.
Cipher Mining (CIFR) — Cantor Fitzgerald lowered its price target to $15.00 from $19.00 and listed a Overweight rating.
Cipher Mining (CIFR) — JPMorgan Chase & Co. lowered its price target to $18.00 from $22.00 and listed a Overweight rating.
Cipher Mining (CIFR) — Needham & Company LLC lowered its price target to $15.00 from $25.00 and listed a Buy rating.
Cipher Mining (CIFR) — Rosenblatt Securities lowered its price target to $19.00 from $30.00 and listed a Buy rating.
Cipher Mining (CIFR) — UBS Group reiterated its Overweight rating with a $18.00 price target.
Cipher Mining (CIFR) — Wells Fargo & Company lowered its price target to $15.00 from $25.00 and listed a Overweight rating.
Civeo (CVEO) — Stifel Nicolaus raised its price target to $42.00 from $37.00 and listed a Buy rating.
Clorox (CLX) — Cantor Fitzgerald reiterated its Overweight rating.
Clorox (CLX) — JPMorgan Chase & Co. raised its price target to $86.00 from $83.00 and listed a Underweight rating.
Clorox (CLX) — TD Cowen reiterated its Hold rating.
Clorox (CLX) — The Goldman Sachs Group reiterated its Sell rating with a $74.00 price target.
Clorox (CLX) — UBS Group raised its price target to $96.00 from $91.00 and listed a Neutral rating.
Clorox (CLX) — UBS Group set its price target to $88.00.
Clorox (CLX) — Wells Fargo & Company raised its price target to $90.00 from $85.00 and listed a Equal Weight rating.
Cloudflare (NET) — Craig Hallum upgraded the stock to Buy.
Cloudflare (NET) — Fox Advisors downgraded the stock to Neutral.
Cloudflare (NET) — JPMorgan upgraded the stock to Overweight from Neutral with a $350 price target.
Cloudflare (NET) — Morgan Stanley initiated coverage with a Overweight rating.
Cloudflare (NET) — Oppenheimer initiated coverage with a Outperform rating.
Cloudflare (NET) — Raymond James Financial downgraded the stock to Underperform from Strong-Buy.
Cloudflare (NET) — Stephens initiated coverage with a Overweight rating.
Cloudflare (NET) — TD Cowen downgraded the stock to Hold from Buy.
Cloudflare (NET) — UBS Group initiated coverage with a Buy rating.
Cloudflare (NET) — Wedbush initiated coverage with a Outperform rating.
Coca Cola FEMSA (KOF) — Barclays raised its price target to $125.00 from $122.00 and listed a Equal Weight rating.
Coca Cola FEMSA (KOF) — Itau BBA Securities downgraded the stock to Market Perform from Outperform with a $116.00 price target.
Coca-Cola FEMSA (KOF) — Itau BBA downgraded the stock to Market Perform from Outperform with a $116 price target.
Coinbase Global (COIN) — Keefe, Bruyette & Woods lowered its price target to $221.00 from $237.00 and listed a Outperform rating.
Colgate-Palmolive (CL) — Barclays raised its price target to $95.00 from $87.00 and listed a Equal Weight rating.
Columbia Banking System (COLB) — Barclays raised its price target to $34.00 from $32.00 and listed a Equal Weight rating.
Community Health Systems (CYH) — Truist Financial lowered its price target to $2.50 from $3.25 and listed a Hold rating.
Community Health Systems (CYH) — Wells Fargo & Company lowered its price target to $1.00 from $2.00 and listed a Underweight rating.
Compass Pathways (CMPS) — BTIG Research reiterated its Buy rating with a $25.00 price target.
CRISPR Therapeutics (CRSP) — Citigroup reiterated its Market Outperform rating.
CRISPR Therapeutics (CRSP) — Needham & Company LLC reiterated its Buy rating with a $82.00 price target.
CSW Industrials (CSW) — Citigroup lowered its price target to $326.00 from $340.00 and listed a Neutral rating.
D.R. Horton (DHI) — Morgan Stanley lowered its price target to $130.00 from $151.00 and listed a Equal Weight rating.
D.R. Horton (DHI) — Raymond James downgraded the stock to Underperform from Market Perform.
D.R. Horton (DHI) — Raymond James Financial downgraded the stock to Underperform from Market Perform.
DraftKings (DKNG) — Sanford C. Bernstein lowered its price target to $27.00 from $29.00 and listed a Outperform rating.
Dropbox (DBX) — Stephens initiated coverage with a Equal Weight rating and a $39 price target.
DT Midstream (DTM) — Morgan Stanley lowered its price target to $161.00 from $164.00 and listed a Overweight rating.
DT Midstream (DTM) — Scotiabank lowered its price target to $161.00 from $165.00 and listed a Sector Outperform rating.
Dynatrace (DT) — BTIG Research lowered its price target to $63.00 from $73.00 and listed a Buy rating.
Dynatrace (DT) — Needham & Company LLC lowered its price target to $65.00 from $68.00 and listed a Buy rating.
East West Bancorp (EWBC) — Barclays raised its price target to $160.00 from $155.00 and listed a Overweight rating.
Eastern Bankshares (EBC) — Barclays raised its price target to $24.00 from $23.00 and listed a Equal Weight rating.
Eastman Chemical (EMN) — Citigroup lowered its price target to $75.00 from $76.00 and listed a Buy rating.
Emerson Electric (EMR) — Morgan Stanley lowered its price target to $140.00 from $145.00 and listed a Underweight rating.
Entergy (ETR) — BTIG Research reiterated its Buy rating with a $124.00 price target.
Equity Lifestyle Properties (ELS) — Truist Financial lowered its price target to $63.00 from $64.00 and listed a Hold rating.
Ero Copper (ERO) — Scotiabank upgraded the stock to Sector Outperform from Sector Perform.
Essential Properties Realty Trust (EPRT) — Cantor Fitzgerald lowered its price target to $31.00 from $37.00 and listed a Overweight rating.
Estee Lauder Companies (EL) — Citigroup raised its price target to $121.00 from $115.00 and listed a Buy rating.
Estee Lauder Companies (EL) — JPMorgan Chase & Co. raised its price target to $120.00 from $115.00 and listed a Overweight rating.
Estee Lauder Companies (EL) — Morgan Stanley raised its price target to $118.00 from $112.00 and listed a Equal Weight rating.
Estee Lauder Companies (EL) — Royal Bank Of Canada raised its price target to $126.00 from $120.00 and listed a Outperform rating.
Estee Lauder Companies (EL) — UBS Group raised its price target to $112.00 from $104.00 and listed a Neutral rating.
Estee Lauder Companies (EL) — Wells Fargo & Company raised its price target to $110.00 from $95.00 and listed a Equal Weight rating.
EverQuote (EVER) — B. Riley Financial reiterated its Buy rating with a $35.00 price target.
EverQuote (EVER) — Canaccord Genuity Group raised its price target to $32.00 from $28.00 and listed a Buy rating.
EverQuote (EVER) — Cantor Fitzgerald reiterated its Overweight rating.
EverQuote (EVER) — Citigroup reiterated its Buy rating.
EverQuote (EVER) — JPMorgan Chase & Co. raised its price target to $30.00 from $29.00 and listed a Overweight rating.
EverQuote (EVER) — Needham & Company LLC raised its price target to $35.00 from $30.00 and listed a Buy rating.
EVgo (EVGO) — Cantor Fitzgerald downgraded the stock to Neutral from Overweight with a $2.00 price target.
Expedia Group (EXPE) — UBS Group lowered its price target to $328.00 from $351.00 and listed a Neutral rating.
Exzeo Group (XZO) — Truist Financial reiterated its Buy rating with a $24.00 price target.
Fabrinet (FN) — JPMorgan Chase & Co. raised its price target to $470.00 from $465.00 and listed a Neutral rating.
Fabrinet (FN) — Needham & Company LLC reiterated its Buy rating with a $500.00 price target.
Fabrinet (FN) — Rosenblatt Securities lowered its price target to $600.00 from $750.00 and listed a Buy rating.
Federated Hermes (FHI) — Royal Bank Of Canada raised its price target to $63.00 from $60.00 and listed a Sector Perform rating.
FedEx (FDX) — Raymond James Financial set its price target to $162.00.
FIGS (FIGS) — Barclays raised its price target to $24.00 from $20.00 and listed a Overweight rating.
Flagstar Bank, National Association (FLG) — Barclays lowered its price target to $13.00 from $14.00 and listed a Overweight rating.
Fluence Energy (FLNC) — The Goldman Sachs Group lowered its price target to $7.00 from $9.00 and listed a Neutral rating.
Flutter Entertainment (FLUT) — Sanford C. Bernstein lowered its price target to $100.00 from $110.00 and listed a Market Perform rating.
FMC (FMC) — Citigroup raised its price target to $7.00 from $6.00 and listed a Neutral rating.
FMC (FMC) — UBS Group lowered its price target to $6.50 from $10.00 and listed a Neutral rating.
Fomento Economico Mexicano (FMX) — Barclays raised its price target to $140.00 from $138.00 and listed a Equal Weight rating.
FOX (FOXA) — JPMorgan Chase & Co. raised its price target to $83.00 from $82.00 and listed a Overweight rating.
GE HealthCare Technologies (GEHC) — UBS Group raised its price target to $80.00 from $73.00 and listed a Neutral rating.
GE Vernova (GEV) — Argus lowered its price target to $1,100.00 from $1,300.00 and listed a Buy rating.
General Dynamics (GD) — Morgan Stanley raised its price target to $480.00 from $465.00 and listed a Overweight rating.
General Dynamics (GD) — Sanford C. Bernstein raised its price target to $386.00 from $365.00 and listed a Market Perform rating.
General Fusion Group Ltd. (GFUZ) — Wedbush initiated coverage with a Neutral rating and a $7 price target.
GFL Environmental (GFL) — Truist Financial lowered its price target to $55.00 from $60.00 and listed a Buy rating.
Gildan Activewear (GIL) — Scotiabank reiterated its Sector Outperform rating with a $53.00 price target.
Grab (GRAB) — JPMorgan Chase & Co. raised its price target to $5.10 from $4.80 and listed a Overweight rating.
Halozyme Therapeutics (HALO) — JPMorgan Chase & Co. raised its price target to $79.00 from $78.00 and listed a Neutral rating.
Harmonic (HLIT) — Barclays lowered its price target to $14.00 from $16.00 and listed a Equal Weight rating.
HCA Healthcare (HCA) — Truist Financial reiterated its Buy rating with a $510.00 price target.
HealthStream (HSTM) — Craig Hallum downgraded the stock to Hold from Buy with a $40 price target.
Hilton Worldwide (HLT) — Citigroup raised its price target to $400.00 from $335.00 and listed a Neutral rating.
Hinge Health (HNGE) — Canaccord Genuity Group raised its price target to $134.00 from $105.00 and listed a Buy rating.
Hinge Health (HNGE) — Morgan Stanley raised its price target to $131.00 from $117.00 and listed a Overweight rating.
Hinge Health (HNGE) — Needham & Company LLC raised its price target to $135.00 from $115.00 and listed a Buy rating.
Hinge Health (HNGE) — Royal Bank Of Canada raised its price target to $135.00 from $110.00 and listed a Outperform rating.
Hinge Health (HNGE) — Stifel Nicolaus raised its price target to $135.00 from $130.00 and listed a Buy rating.
Hinge Health (HNGE) — Truist Financial raised its price target to $145.00 from $112.00 and listed a Buy rating.
Hinge Health (HNGE) — Wells Fargo & Company raised its price target to $132.00 from $103.00 and listed a Overweight rating.
Hippo (HIPO) — Keefe, Bruyette & Woods raised its price target to $37.00 from $35.00 and listed a Market Perform rating.
Howmet Aerospace (HWM) — KeyBanc Capital Markets upgraded the stock to Overweight from Sector Weight with a $237 price target.
Huntington Ingalls Industries (HII) — JPMorgan Chase & Co. raised its price target to $375.00 from $370.00 and listed a Neutral rating.
Huntington Ingalls Industries (HII) — Sanford C. Bernstein raised its price target to $352.00 from $304.00 and listed a Market Perform rating.
Ibotta (IBTA) — Evercore set its price target to $58.00.
Ibotta (IBTA) — Goldman Sachs upgraded the stock to Neutral from Sell with a $58 price target.
Ibotta (IBTA) — Needham & Company LLC raised its price target to $65.00 from $45.00 and listed a Buy rating.
Ibotta (IBTA) — Wells Fargo & Company raised its price target to $49.00 from $40.00 and listed a Equal Weight rating.
Ichor (ICHR) — B. Riley Financial lowered its price target to $70.00 from $85.00 and listed a Buy rating.
Ichor (ICHR) — Needham & Company LLC lowered its price target to $55.00 from $88.00 and listed a Buy rating.
Ichor (ICHR) — Stifel Nicolaus lowered its price target to $93.00 from $115.00 and listed a Buy rating.
Ichor (ICHR) — TD Cowen lowered its price target to $55.00 from $100.00 and listed a Buy rating.
IDACORP (IDA) — Barclays raised its price target to $163.00 from $149.00 and listed a Overweight rating.
IDEXX Laboratories (IDXX) — Morgan Stanley raised its price target to $810.00 from $805.00 and listed a Overweight rating.
IDEXX Laboratories (IDXX) — UBS Group raised its price target to $700.00 from $627.00 and listed a Neutral rating.
Independent Bank (INDB) — Barclays raised its price target to $86.00 from $82.00 and listed a Underweight rating.
Inspire Medical Systems (INSP) — Barclays lowered its price target to $62.00 from $65.00 and listed a Underweight rating.
Inspire Medical Systems (INSP) — JPMorgan Chase & Co. raised its price target to $65.00 from $60.00 and listed a Neutral rating.
Inspire Medical Systems (INSP) — Piper Sandler raised its price target to $70.00 from $60.00 and listed a Neutral rating.
Inspire Medical Systems (INSP) — Robert W. Baird raised its price target to $77.00 from $73.00 and listed a Neutral rating.
Inspire Medical Systems (INSP) — Truist Financial reiterated its Hold rating with a $76.00 price target.
Inspire Medical Systems (INSP) — Wells Fargo & Company raised its price target to $69.00 from $56.00 and listed a Equal Weight rating.
Iovance Biotherapeutics (IOVA) — UBS Group raised its price target to $8.00 from $7.00 and listed a Neutral rating.
Jazz Pharmaceuticals (JAZZ) — Barclays raised its price target to $275.00 from $271.00 and listed a Overweight rating.
Jazz Pharmaceuticals (JAZZ) — JPMorgan Chase & Co. raised its price target to $310.00 from $300.00 and listed a Overweight rating.
Jazz Pharmaceuticals (JAZZ) — Morgan Stanley raised its price target to $319.00 from $314.00 and listed a Overweight rating.
Jazz Pharmaceuticals (JAZZ) — Royal Bank Of Canada raised its price target to $305.00 from $296.00 and listed a Outperform rating.
Jersey Mike’s (JMKE) — Guggenheim lowered its price target to $28.00 from $29.00 and listed a Buy rating.
KB Home (KBH) — Morgan Stanley lowered its price target to $37.00 from $39.00 and listed a Underweight rating.
Kinder Morgan (KMI) — Morgan Stanley lowered its price target to $39.00 from $40.00 and listed a Equal Weight rating.
KKR Real Estate Finance Trust (KREF) — Keefe, Bruyette & Woods lowered its price target to $5.50 from $6.50 and listed a Market Perform rating.
Krystal Biotech (KRYS) — Citigroup lowered its price target to $412.00 from $416.00 and listed a Buy rating.
Krystal Biotech (KRYS) — Royal Bank Of Canada lowered its price target to $375.00 from $400.00 and listed a Outperform rating.
Krystal Biotech (KRYS) — TD Cowen lowered its price target to $380.00 from $403.00 and listed a Buy rating.
L3Harris Technologies (LHX) — Bank of America raised its price target to $375.00 from $325.00 and listed a Buy rating.
Lattice Semiconductor (LSCC) — Robert W. Baird set its price target to $195.00.
Lattice Semiconductor (LSCC) — Rosenblatt Securities raised its price target to $200.00 from $175.00 and listed a Buy rating.
Lattice Semiconductor (LSCC) — Stifel Nicolaus raised its price target to $175.00 from $165.00 and listed a Buy rating.
Lennar (LEN) — Morgan Stanley lowered its price target to $58.00 from $65.00 and listed a Underweight rating.
Lsb Industries (LXU) — UBS Group raised its price target to $12.50 from $12.00 and listed a Neutral rating.
Lumentum (LITE) — B. Riley Financial downgraded the stock to Neutral from Buy with a $770.00 price target.
Lumentum (LITE) — B. Riley Securities downgraded the stock to Neutral from Buy with a $770 price target.
Lumentum (LITE) — Needham & Company LLC lowered its price target to $800.00 from $1,040.00 and listed a Buy rating.
Lumentum (LITE) — Rosenblatt Securities lowered its price target to $900.00 from $1,300.00 and listed a Buy rating.
Lumentum (LITE) — Susquehanna lowered its price target to $950.00 from $1,100.00 and listed a Positive rating.
Lumentum (LITE) — TD Cowen lowered its price target to $685.00 from $820.00 and listed a Hold rating.
Lyell Immunopharma (LYEL) — Needham & Company LLC reiterated its Buy rating with a $44.00 price target.
LyondellBasell Industries (LYB) — Citigroup raised its price target to $74.00 from $63.00 and listed a Neutral rating.
LyondellBasell Industries (LYB) — UBS Group raised its price target to $69.00 from $62.00 and listed a Neutral rating.
Madrigal Pharmaceuticals (MDGL) — Citigroup raised its price target to $760.00 from $725.00 and listed a Buy rating.
ManpowerGroup (MAN) — BNP Paribas Exane downgraded the stock to Neutral from Outperform with a $52.50 price target.
Marriott International (MAR) — Barclays raised its price target to $409.00 from $363.00 and listed a Equal Weight rating.
Marriott International (MAR) — Robert W. Baird raised its price target to $414.00 from $395.00 and listed a Neutral rating.
Marriott International (MAR) — The Goldman Sachs Group raised its price target to $456.00 from $406.00 and listed a Buy rating.
Marriott International (MAR) — Wells Fargo & Company raised its price target to $463.00 from $426.00 and listed a Overweight rating.
Marsh McLennan (MRSH) — BMO Capital Markets upgraded the stock to Outperform from Market Perform with a $230 price target.
Marvell Technology (MRVL) — B. Riley Financial lowered its price target to $275.00 from $365.00 and listed a Buy rating.
Marvell Technology (MRVL) — BofA Securities downgraded the stock to Neutral from Buy with a $225 price target.
Marvell Technology (MRVL) — Cantor Fitzgerald lowered its price target to $225.00 from $350.00 and listed a Neutral rating.
Marvell Technology (MRVL) — Needham & Company LLC lowered its price target to $300.00 from $400.00 and listed a Buy rating.
Marvell Technology (MRVL) — Royal Bank Of Canada lowered its price target to $250.00 from $425.00 and listed a Outperform rating.
Marvell Technology (MRVL) — Susquehanna lowered its price target to $300.00 from $340.00 and listed a Positive rating.
Marvell Technology (MRVL) — TD Cowen downgraded the stock to Hold from Buy with a $175 price target.
Marvell Technology (MRVL) — UBS Group reiterated its Buy rating.
Marvell Technology (MRVL) — Wells Fargo & Company lowered its price target to $285.00 from $365.00 and listed a Overweight rating.
Match Group (MTCH) — Barclays raised its price target to $52.00 from $51.00 and listed a Overweight rating.
Match Group (MTCH) — BTIG Research reiterated its Neutral rating.
Match Group (MTCH) — Citigroup raised its price target to $45.00 from $39.00 and listed a Neutral rating.
Match Group (MTCH) — Needham & Company LLC upgraded the stock to Buy.
Match Group (MTCH) — Susquehanna raised its price target to $50.00 from $45.00 and listed a Positive rating.
Match Group (MTCH) — Truist Financial raised its price target to $44.00 from $41.00 and listed a Hold rating.
Match Group (MTCH) — UBS Group raised its price target to $43.00 from $38.00 and listed a Neutral rating.
Match Group (MTCH) — Wells Fargo & Company lowered its price target to $38.00 from $39.00 and listed a Equal Weight rating.
Mechanics Bancorp (MCHB) — Cantor Fitzgerald lowered its price target to $16.00 from $17.00 and listed a Overweight rating.
Medical Properties Trust (MPT) — BNP Paribas Exane downgraded the stock to Neutral from Outperform with a $2.25 price target.
Merck (MRK) — DZ Bank downgraded the stock to Hold from Buy with a $153 price target.
Meridian Bank (MRBK) — DA Davidson downgraded the stock to Neutral from Buy with a $20 price target.
Mistras Group (MG) — Roth Capital downgraded the stock to Neutral from Buy with a $20.35 price target.
MNTN (MNTN) — Freedom Broker initiated coverage with a Buy rating and a $16.50 price target.
monday.com (MNDY) — Guggenheim reiterated its Buy rating with a $130.00 price target.
monday.com (MNDY) — Morgan Stanley set its price target to $105.00.
Monday.com (MNDY) — TD Cowen downgraded the stock to Hold from Buy with a $105 price target.
Nabors Industries (NBR) — Piper Sandler raised its price target to $145.00 from $130.00 and listed a Overweight rating.
NANO Nuclear Energy (NNE) — Wedbush initiated coverage with a Outperform rating and a $18 price target.
NAPCO Security Technologies (NSSC) — TD Cowen lowered its price target to $45.00 from $55.00 and listed a Buy rating.
Neurocrine Biosciences (NBIX) — Canaccord Genuity Group raised its price target to $220.00 from $210.00 and listed a Buy rating.
Neurocrine Biosciences (NBIX) — Morgan Stanley raised its price target to $185.00 from $183.00 and listed a Equal Weight rating.
Neurocrine Biosciences (NBIX) — Piper Sandler raised its price target to $215.00 from $210.00 and listed a Overweight rating.
Neurocrine Biosciences (NBIX) — Royal Bank Of Canada raised its price target to $190.00 from $187.00 and listed a Outperform rating.
Nextpower (NXT) — Glj Research raised its price target to $158.00 from $149.00 and listed a Buy rating.
nLight (LASR) — Needham & Company LLC initiated coverage with a Buy rating and a $50.00 price target.
NuScale Power (SMR) — Wedbush initiated coverage with a Underperform rating and a $5 price target.
NVR (NVR) — Morgan Stanley lowered its price target to $4,864.00 from $5,058.00 and listed a Underweight rating.
Oklo Inc. (OKLO) — Wedbush resumed coverage with a Outperform rating and a $36 price target.
Olin (OLN) — Wells Fargo & Company raised its price target to $17.00 from $16.00 and listed a Equal Weight rating.
ON (ONON) — BTIG Research reiterated its Buy rating with a $60.00 price target.
ON (ONON) — Cantor Fitzgerald upgraded the stock to Buy.
Once Upon a Farm (OFRM) — BofA Securities downgraded the stock to Underperform from Buy with a $10 price target.
Once Upon A Farm (OFRM) — TD Cowen lowered its price target to $13.00 from $18.00 and listed a Hold rating.
OneMain (OMF) — Truist Financial lowered its price target to $70.00 from $71.00 and listed a Buy rating.
ONEOK (OKE) — Scotiabank raised its price target to $97.00 from $96.00 and listed a Sector Perform rating.
onsemi (ON) — B. Riley Financial lowered its price target to $97.00 from $105.00 and listed a Buy rating.
onsemi (ON) — Cantor Fitzgerald reiterated its Neutral rating with a $90.00 price target.
onsemi (ON) — Craig Hallum upgraded the stock to Buy from Hold with a $85 price target.
onsemi (ON) — DA Davidson set its price target to $110.00.
onsemi (ON) — Needham & Company LLC reiterated its Buy rating with a $116.00 price target.
onsemi (ON) — Rosenblatt Securities lowered its price target to $80.00 from $85.00 and listed a Neutral rating.
onsemi (ON) — TD Cowen reiterated its Hold rating with a $75.00 price target.
onsemi (ON) — Truist Financial raised its price target to $76.00 from $75.00 and listed a Hold rating.
onsemi (ON) — Wells Fargo & Company lowered its price target to $90.00 from $100.00 and listed a Overweight rating.
Oppenheimer (OPY) — Needham & Company LLC upgraded the stock to Outperform.
Oshkosh (OSK) — Morgan Stanley lowered its price target to $139.00 from $147.00 and listed a Equal Weight rating.
Palantir Technologies (PLTR) — Citigroup raised its price target to $265.00 from $250.00 and listed a Buy rating.
Palantir Technologies (PLTR) — DA Davidson reiterated its Buy rating with a $250.00 price target.
Palantir Technologies (PLTR) — Morgan Stanley raised its price target to $233.00 from $205.00 and listed a Buy rating.
Palantir Technologies (PLTR) — Piper Sandler reiterated its Overweight rating with a $235.00 price target.
Palantir Technologies (PLTR) — Rosenblatt Securities reiterated its Buy rating with a $260.00 price target.
Palantir Technologies (PLTR) — Royal Bank Of Canada raised its price target to $130.00 from $90.00 and listed a Underperform rating.
Palantir Technologies (PLTR) — The Goldman Sachs Group reiterated its Buy rating with a $235.00 price target.
Palantir Technologies (PLTR) — Truist Financial reiterated its Buy rating with a $250.00 price target.
Palantir Technologies (PLTR) — UBS Group reiterated its Buy rating.
Patterson-UTI Energy (PTEN) — Piper Sandler raised its price target to $15.00 from $14.00 and listed a Overweight rating.
Penske Automotive Group (PAG) — Barclays raised its price target to $212.00 from $210.00 and listed a Overweight rating.
Philip Morris International (PM) — Stifel Nicolaus raised its price target to $232.00 from $205.00 and listed a Buy rating.
Piper Sandler Companies (PIPR) — Bank of America reiterated its Underperform rating with a $69.00 price target.
Pony AI (PONY) — Morgan Stanley initiated coverage with a Overweight rating and a $10 price target.
Powerus (PUSA) — Northland Securities initiated coverage with a Outperform rating and a $5.00 price target.
Powerus Corporation (PUSA) — Northland Capital initiated coverage with a Outperform rating and a $5 price target.
Precision Drilling (PDS) — Piper Sandler raised its price target to $115.00 from $105.00 and listed a Overweight rating.
Primis Financial (FRST) — Keefe, Bruyette & Woods lowered its price target to $17.00 from $18.00 and listed a Outperform rating.
Protagonist Therapeutics (PTGX) — UBS Group reiterated its Buy rating.
Public Service Enterprise Group (PEG) — Wells Fargo & Company lowered its price target to $87.00 from $89.00 and listed a Overweight rating.
PulteGroup (PHM) — Morgan Stanley lowered its price target to $120.00 from $128.00 and listed a Equal Weight rating.
Realty Income (O) — Royal Bank Of Canada raised its price target to $61.00 from $60.00 and listed a Outperform rating.
Retension Pharmaceuticals (RTSN) — Oppenheimer initiated coverage with a Outperform rating and a $50.00 price target.
Rexford Industrial Realty (REXR) — Truist Financial raised its price target to $42.00 from $39.00 and listed a Buy rating.
Roku (ROKU) — BMO Capital Markets upgraded the stock to Outperform from Market Perform.
Roku (ROKU) — Needham & Company LLC reiterated its Buy rating.
Roku (ROKU) — Rosenblatt Securities downgraded the stock to Neutral from Buy with a $160.00 price target.
SBA Communications (SBAC) — Citigroup reiterated its Market Outperform rating.
SBA Communications (SBAC) — Citigroup lowered its price target to $225.00 from $235.00 and listed a Buy rating.
SBA Communications (SBAC) — JPMorgan Chase & Co. lowered its price target to $200.00 from $220.00 and listed a Neutral rating.
SBA Communications (SBAC) — TD Cowen raised its price target to $239.00 from $229.00 and listed a Buy rating.
SBA Communications (SBAC) — Wells Fargo & Company set its price target to $200.00.
ServiceNow (NOW) — Argus reiterated its Buy rating with a $170.00 price target.
SiBone (SIBN) — Citigroup reiterated its Market Outperform rating.
SiBone (SIBN) — Needham & Company LLC lowered its price target to $26.00 from $27.00 and listed a Buy rating.
SiBone (SIBN) — TD Cowen raised its price target to $23.00 from $20.00 and listed a Buy rating.
SiBone (SIBN) — UBS Group raised its price target to $26.00 from $25.00 and listed a Buy rating.
Sierra Bancorp (BSRR) — Keefe, Bruyette & Woods raised its price target to $44.00 from $42.00 and listed a Market Perform rating.
Sirius XM (SIRI) — Goldman Sachs upgraded the stock to Buy from Neutral with a $37 price target.
Sirius XM (SIRI) — JPMorgan Chase & Co. lowered its price target to $32.00 from $34.00 and listed a Neutral rating.
SiTime (SITM) — Rosenblatt Securities raised its price target to $900.00 from $750.00 and listed a Buy rating.
Smurfit Westrock (SW) — Barclays lowered its price target to $55.00 from $56.00 and listed a Overweight rating.
SoFi Technologies (SOFI) — Truist Financial raised its price target to $17.00 from $16.00 and listed a Hold rating.
Sportsman’s Warehouse (SPWH) — LADENBURG THALM/SH SH initiated coverage with a Buy rating and a $2.60 price target.
Sportsman’s Warehouse (SPWH) — Ladenburg Thalmann initiated coverage with a Buy rating and a $2.60 price target.
Starbucks (SBUX) — Stephens initiated coverage with a Equal Weight rating and a $39.00 price target.
Strategy (MSTR) — B. Riley Financial lowered its price target to $180.00 from $195.00 and listed a Buy rating.
Strattec Security (STRT) — Freedom Broker upgraded the stock to Buy from Hold with a $79.00 price target.
Strattec Security (STRT) — Wedbush set its price target to $79.00.
Sun Communities (SUI) — Citigroup reiterated its Market Outperform rating.
Sun Communities (SUI) — Truist Financial lowered its price target to $129.00 from $136.00 and listed a Buy rating.
Superior Group of Companies (SGC) — Cantor Fitzgerald reiterated its Buy rating.
Syndax Pharmaceuticals (SNDX) — HC Wainwright lowered its price target to $36.00 from $38.00 and listed a Buy rating.
Syndax Pharmaceuticals (SNDX) — Mizuho set its price target to $43.00.
Tactile Systems Technology (TCMD) — BTIG Research lowered its price target to $31.00 from $35.00 and listed a Buy rating.
TAT Technologies (TATT) — B. Riley Financial reiterated its Buy rating with a $63.00 price target.
TAT Technologies (TATT) — UBS Group reiterated its Buy rating.
TechnipFMC (FTI) — Piper Sandler raised its price target to $88.00 from $85.00 and listed a Overweight rating.
Teledyne Technologies (TDY) — Morgan Stanley raised its price target to $725.00 from $715.00 and listed a Equal Weight rating.
Tempus AI (TEM) — BTIG Research raised its price target to $100.00 from $80.00 and listed a Buy rating.
Tempus AI (TEM) — Cantor Fitzgerald raised its price target to $92.00 from $80.00 and listed a Overweight rating.
Tempus AI (TEM) — HC Wainwright raised its price target to $85.00 from $68.00 and listed a Buy rating.
Tempus AI (TEM) — Jefferies upgraded the stock to Hold from Underperform with a $70 price target.
Tempus AI (TEM) — Jefferies Financial Group upgraded the stock to Hold from Underperform with a $70.00 price target.
Tempus AI (TEM) — Robert W. Baird raised its price target to $92.00 from $85.00 and listed a Outperform rating.
Tenet Healthcare (THC) — KeyCorp raised its price target to $300.00 from $270.00 and listed a Overweight rating.
Tenet Healthcare (THC) — Truist Financial reiterated its Buy rating with a $305.00 price target.
Terrestrial Energy (IMSR) — Wedbush initiated coverage with a Neutral rating and a $4 price target.
Texas Capital Bancshares (TCBI) — Barclays raised its price target to $110.00 from $100.00 and listed a Equal Weight rating.
Textron (TXT) — Bank of America reiterated its Neutral rating with a $100.00 price target.
The Ensign Group (ENSG) — Royal Bank Of Canada raised its price target to $239.00 from $228.00 and listed a Outperform rating.
Third Coast Bancshares (TCBX) — Keefe, Bruyette & Woods lowered its price target to $46.00 from $48.00 and listed a Market Perform rating.
Toll Brothers (TOL) — Morgan Stanley raised its price target to $170.00 from $159.00 and listed a Overweight rating.
Tower Semiconductor (TSEM) — DA Davidson set its price target to $335.00.
Tower Semiconductor (TSEM) — Stifel Nicolaus lowered its price target to $235.00 from $270.00 and listed a Buy rating.
Tower Semiconductor (TSEM) — Susquehanna lowered its price target to $305.00 from $355.00 and listed a Positive rating.
Tower Semiconductor (TSEM) — Wedbush lowered its price target to $190.00 from $300.00 and listed a Neutral rating.
Towne Bank (TOWN) — Keefe, Bruyette & Woods raised its price target to $39.00 from $38.00 and listed a Market Perform rating.
TRex Bio, Inc. (TRXB) — Cantor Fitzgerald initiated coverage with a Overweight rating.
TRex Bio, Inc. (TRXB) — JPMorgan initiated coverage with a Overweight rating and a $20 price target.
TRex Bio, Inc. (TRXB) — Stifel initiated coverage with a Buy rating and a $39 price target.
TripAdvisor (TRIP) — UBS Group lowered its price target to $10.00 from $12.00 and listed a Neutral rating.
Trivago N.V. ADS (TRVG) — UBS Group lowered its price target to $4.80 from $6.00 and listed a Neutral rating.
Twilio (TWLO) — HSBC upgraded the stock to Hold from Reduce with a $215.00 price target.
Twilio (TWLO) — HSBC Securities upgraded the stock to Hold from Reduce with a $215 price target.
Tyler Technologies (TYL) — The Goldman Sachs Group raised its price target to $385.00 from $345.00 and listed a Neutral rating.
UMB Financial (UMBF) — Barclays raised its price target to $185.00 from $175.00 and listed a Overweight rating.
Upstart (UPST) — BTIG Research lowered its price target to $40.00 from $43.00 and listed a Buy rating.
Upstart (UPST) — Needham & Company LLC lowered its price target to $30.00 from $42.00 and listed a Buy rating.
Upwork (UPWK) — BTIG Research reiterated its Neutral rating.
Upwork (UPWK) — Needham & Company LLC raised its price target to $13.00 from $11.00 and listed a Buy rating.
Upwork (UPWK) — Royal Bank Of Canada reiterated its Sector Perform rating with a $8.00 price target.
Upwork (UPWK) — Scotiabank raised its price target to $10.00 from $8.00 and listed a Sector Perform rating.
Upwork (UPWK) — UBS Group raised its price target to $10.00 from $9.00 and listed a Neutral rating.
V2X (VVX) — Royal Bank Of Canada raised its price target to $88.00 from $81.00 and listed a Sector Perform rating.
V2X (VVX) — Truist Financial reiterated its Hold rating with a $87.00 price target.
Vale (VALE) — Wells Fargo & Company lowered its price target to $13.00 from $15.00 and listed a Equal Weight rating.
Valley National Bancorp (VLY) — Barclays raised its price target to $17.00 from $15.00 and listed a Equal Weight rating.
Verra Mobility (VRRM) — JPMorgan downgraded the stock to Underweight from Neutral.
Vertex Pharmaceuticals (VRTX) — Cantor Fitzgerald raised its price target to $619.00 from $595.00 and listed a Overweight rating.
Vertex Pharmaceuticals (VRTX) — JPMorgan Chase & Co. raised its price target to $570.00 from $560.00 and listed a Overweight rating.
Vertex Pharmaceuticals (VRTX) — Morgan Stanley lowered its price target to $660.00 from $665.00 and listed a Overweight rating.
Vertex Pharmaceuticals (VRTX) — Royal Bank Of Canada raised its price target to $600.00 from $576.00 and listed a Outperform rating.
Vertex Pharmaceuticals (VRTX) — Scotiabank raised its price target to $660.00 from $558.00 and listed a Sector Outperform rating.
Vertex Pharmaceuticals (VRTX) — Stifel Nicolaus raised its price target to $563.00 from $500.00 and listed a Hold rating.
Vertex Pharmaceuticals (VRTX) — TD Cowen raised its price target to $575.00 from $550.00 and listed a Buy rating.
Vertex Pharmaceuticals (VRTX) — The Goldman Sachs Group raised its price target to $725.00 from $654.00 and listed a Buy rating.
Vertex Pharmaceuticals (VRTX) — UBS Group raised its price target to $640.00 from $615.00 and listed a Buy rating.
Vertex Pharmaceuticals (VRTX) — Wells Fargo & Company raised its price target to $650.00 from $550.00 and listed a Overweight rating.
Victoria’s Secret & Co. (VSXY) — Wells Fargo & Company raised its price target to $120.00 from $100.00 and listed a Overweight rating.
Viper Energy (VNOM) — Oppenheimer downgraded the stock to Market Perform from Outperform with a $53.00 price target.
Walker & Dunlop (WD) — Keefe, Bruyette & Woods lowered its price target to $43.00 from $45.00 and listed a Outperform rating.
Waystar (WAY) — Canaccord Genuity Group raised its price target to $34.00 from $33.00 and listed a Buy rating.
Waystar (WAY) — TD Cowen lowered its price target to $39.00 from $42.00 and listed a Buy rating.
Wealthfront (WLTH) — Wells Fargo & Company raised its price target to $12.00 from $11.50 and listed a Overweight rating.
Western Alliance Bancorporation (WAL) — Barclays raised its price target to $95.00 from $93.00 and listed a Overweight rating.
Wintrust Financial (WTFC) — Barclays raised its price target to $195.00 from $190.00 and listed a Overweight rating.
World Kinect (WKC) — Morgan Stanley raised its price target to $32.00 from $30.00 and listed a Underweight rating.
X-Energy (XE) — Wedbush initiated coverage with a Outperform rating and a $17 price target.
Zillow Group (ZG) — KeyCorp lowered its price target to $42.00 from $48.00 and listed a Overweight rating.
Zillow Group (ZG) — Royal Bank Of Canada lowered its price target to $45.00 from $55.00 and listed a Outperform rating.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
Related research
How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business
STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)
Bank of Canada Looks to Pause rates as Recession Looms
American Analyst Updates: Nov 2nd, 2026
American Analyst Updates: Oct 29th, 2026
American Analyst Updates: Oct 28th, 2026
A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.